| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ageing – Oxidative stress, PTMs and disease
|
Ebert, Thomas
|
|
|
86 |
C |
p.
|
article
|
| 2 |
Avenues for post-translational protein modification prevention and therapy
|
Tang, Mengyao
|
|
|
86 |
C |
p.
|
article
|
| 3 |
Biochemical genesis of enzymatic and non-enzymatic post-translational modifications
|
Jennings, Erin Q.
|
|
|
86 |
C |
p.
|
article
|
| 4 |
Chapter 5 – “Parkinson's disease – A role of non-enzymatic posttranslational modifications in disease onset and progression?”
|
Schmidt, Sebastian
|
|
|
86 |
C |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
86 |
C |
p.
|
article
|
| 6 |
Glucose-derived posttranslational modification in cardiovascular disease
|
Lehrke, Michael
|
|
|
86 |
C |
p.
|
article
|
| 7 |
Identification and characterization of post-translational modifications: Clinical implications
|
Hermann, Juliane
|
|
|
86 |
C |
p.
|
article
|
| 8 |
Impact of post-translational modification on the genesis and progression of diseases
|
Wu, Zhuojun
|
|
|
86 |
C |
p.
|
article
|
| 9 |
Irreversible post-translational modifications – Emerging cardiovascular risk factors
|
Wu, Zhuojun
|
|
|
86 |
C |
p.
|
article
|
| 10 |
Pathological implication of protein post-translational modifications in cancer
|
Pan, Sheng
|
|
|
86 |
C |
p.
|
article
|
| 11 |
Renal insufficiency and chronic kidney disease – Promotor or consequence of pathological post-translational modifications
|
Laget, Jonas
|
|
|
86 |
C |
p.
|
article
|
Journal description